UCI – Das Tumorzentrum Bern - Navigation

Peng, Ren-Wang

{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Tang, J., Su, M., Xiao, Y., Ou, W., Wang, W., Peng, R.-W., \u0026 Wu, Z. (2025). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219739\u0022\u003EThe role of LncRNA SNHG3 in human cancers.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EDiscover Oncology\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(1), 1812.","year":2025,"type":"Journal Article (Review)"},{"title":"Yang, H., Zhu, A., Niu, Y., Ma, W., Xu, K., Jia, Y., Xu, W., Zhao, B., Zhang, E., Jia, J., Liang, S., Dorn, P., Liu, G., Peng, R.-W., \u0026 Yao, F. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219519\u0022\u003EDistinct molecular subtypes of KRASG12C-mutant lung adenocarcinoma: Insights into clinical outcomes, tumour microenvironments and therapeutic strategies\u003C\/a\u003E. \u003Ci\u003EClinical and Translational Medicine\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(10), e70490.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Dai, J., Chen, C., Zhai, Z.-Q., Gao, A.-X., Johnson, D. R., Kopittke, P. M., Zhao, F.-J., \u0026 Wang, P. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/219045\u0022\u003EThe balance between microbial arsenic methylation and demethylation in paddy soils underpins global arsenic risk and straighthead disease in rice\u003C\/a\u003E. \u003Ci\u003EProceedings of the National Academy of Sciences\u003C\/i\u003E, \u003Ci\u003E122\u003C\/i\u003E(38), e2508311122.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Gao, Y., Liu, S., Yin, S., Hu, T., Deng, H., Zhang, T., Heged\u00fcs, B., Marti, T. M., Dorn, P., Liang, S.-Q., Schmid, R. A., Peng, R.-W., \u0026 Shu, Y. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/213965\u0022\u003EDe novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma\u003C\/a\u003E. \u003Ci\u003EEMBO Molecular Medicine\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E, 2258-2298.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Lin, Y., Dubey, C., Losmanov\u00e1, T., Yasmin, S. O., Reymond, J.-L., Peng, R.-W., Deng, H., Dorn, P., \u0026 Marti, T. M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/214747\u0022\u003EInhibition of LDHB triggers DNA damage and increases cisplatin sensitivity in pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003EOncogenesis\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(1), 28.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Zhang, T., Gao, Y., Harhai, M., Jourdain, A. A., Marti, T. M., Vassella, E., Yang, Z., Zhou, Q., Dorn, P., \u0026 Peng, R.-W. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/213445\u0022\u003EPOLR1A inhibits ferroptosis by regulating TFAM-mediated mitophagy and iron homeostasis\u003C\/a\u003E. \u003Ci\u003ERedox Biology\u003C\/i\u003E, \u003Ci\u003E85\u003C\/i\u003E, 103758.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Chriqui, L.-E., Marie, D. N., Sifis, A., Gattlen, C., Ortolini, M., Hao, Y., De Souza Silva, O., Abdelnour-Berchtold, E., Gonzalez, M., Krueger, T., Liaudet, L., Meylan, E., Berezowska, S., Christodoulou, M., Losmanova, T., Peng, R.-W., Marti, T. M., Joyce, J., Cavin, S., \u0026 Perentes, J. Y. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/212079\u0022\u003ELow-dose photodynamic therapy promotes vascular E-selectin expression in chest malignancies, improving immune infiltration and tumor control\u003C\/a\u003E. \u003Ci\u003EJournal for ImmunoTherapy of Cancer\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(6).","year":2025,"type":"Journal Article (Original Article)"},{"title":"Huang, W., Xu, K., Liu, Z., Wang, Y., Chen, Z., Gao, Y., Peng, R.-W., \u0026 Zhou, Q. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177262\u0022\u003ECirculating tumor DNA- and cancer tissue-based next-generation sequencing reveals comparable consistency in targeted gene mutations for advanced or metastatic non-small cell lung cancer\u003C\/a\u003E. \u003Ci\u003EChinese Medical Journal\u003C\/i\u003E, \u003Ci\u003E138\u003C\/i\u003E(7), 851-858.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Xu, W., Yang, H., Xu, K., Zhu, A., Hall, S. R. R., Jia, Y., Zhao, B., Zhang, E., Liu, G., Xu, J., Marti, T. M., Peng, R.-W., Dorn, P., Niu, Y., Pan, X., Zhang, Y., \u0026 Yao, F. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/209524\u0022\u003ETransitional CXCL14+ cancer-associated fibroblasts enhance tumour metastasis and confer resistance to EGFR-TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma\u003C\/a\u003E. \u003Ci\u003EClinical and Translational Medicine\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(4), e70281.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Zhao, L., Deng, H., Zhang, J., Zamboni, N., Yang, H., Gao, Y., Zhang, Y., Xu, D., Zhong, H., van Geest, G., Bruggmann, R., Zhou, Q., Schmid, R. A., Marti, T. M., Dorn, P., \u0026 Peng, R.-W. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194561\u0022\u003ELactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer\u003C\/a\u003E. \u003Ci\u003ECell Death \u0026 Differentiation\u003C\/i\u003E, \u003Ci\u003E32\u003C\/i\u003E(4), 632-645.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Deng, H., Malsiu, F., Ge, H., Losmanov\u00e1, T., Medov\u00e1, M., Zamboni, N., Wang, W., Peng, R.-W., Tang, J., Dorn, P., \u0026 Marti, T. M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/208838\u0022\u003ELDHB silencing enhances the effects of radiotherapy by impairing nucleotide metabolism and promoting persistent DNA damage\u003C\/a\u003E. \u003Ci\u003EScientific Reports\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(1), 10897.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Deng, H., Zhao, L., Ge, H., Gao, Y., Fu, Y., Lin, Y., Masoodi, M., Losmanov\u00e1, T., Medova, M., Ott, J., Su, M., Wang, W., Peng, R.-W., Dorn, P., \u0026 Marti, T. M. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/206695\u0022\u003EUbiquinol-mediated suppression of mitochondria-associated ferroptosis is a targetable function of lactate dehydrogenase B in cancer\u003C\/a\u003E. \u003Ci\u003ENature Communications\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(1), 2597.","year":2025,"type":"Journal Article (Original Article)"},{"title":"Ge, H., Malsiu, F., Gao, Y., Losmanova, T., Blank, F., Ott, J., Medov\u00e1, M., Peng, R.-W., Deng, H., Dorn, P., \u0026 Marti, T. M. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/194372\u0022\u003EInhibition of LDHB suppresses the metastatic potential of lung cancer by reducing mitochondrial GSH catabolism\u003C\/a\u003E. \u003Ci\u003ECancer Letters\u003C\/i\u003E, \u003Ci\u003E611\u003C\/i\u003E, 217353.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Shun-Qing, L., Su, M., Yang, H., Bruggmann, R., Oberhaensli, S., Yang, Z., Gao, Y., Marti, T. M., Wang, W., Schmid, R. A., Shu, Y., Dorn, P., \u0026 Peng, R.-W. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/189025\u0022\u003ECrispr-mediated genome editing reveals a preponderance of non-oncogene addictions as targetable vulnerabilities in pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003ELung Cancer\u003C\/i\u003E, \u003Ci\u003E197\u003C\/i\u003E, 107986.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Karatkevich, D., Losmanov\u00e1, T., Zens, P. I., Deng, H., Dubey, C., Zhang, T., Casty, C., Gao, Y., Neppl, C., Berezowska, S. A., Wang, W., Peng, R.-W., Schmid, R., Dorn, P., \u0026 Marti, T. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179620\u0022\u003EChemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment\u003C\/a\u003E. \u003Ci\u003EScientific Reports\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(18206).","year":2024,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Gao, Y., Yang, H., Spils, M., Marti, T., Losmanov\u00e1, T., Su, M., Wang, W., Zhou, Q., Dorn, P., Shu, Y., \u0026 Peng, R.-W. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/177296\u0022\u003EBAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003EJTO Clinical and Research Reports\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(5), 100672.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Gong, X., Du, J., Peng, R.-W., Chen, C., \u0026 Yang, Z. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/173839\u0022\u003ECRISPRing KRAS: A Winding Road with a Bright Future in Basic and Translational Cancer Research.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(2).","year":2024,"type":"Journal Article (Review)"},{"title":"Qian, J., Liao, G., Chen, M., Peng, R.-W., Yan, X., Du, J., Huang, R., Pan, M., Lin, Y., Gong, X., Xu, G., Zheng, B., Chen, C., \u0026 Yang, Z. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/188938\u0022\u003EAdvancing cancer therapy: new frontiers in targeting DNA damage response.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EFrontiers in Pharmacology\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E, 1474337.","year":2024,"type":"Journal Article (Review)"},{"title":"Deng, H., Ge, H., Dubey, C., Losmanov\u00e1, T., Medova, M., Konstantinidou, G., Mutlu, S. M., Birrer, F. E., Brodie, T. M., Keogh-Stroka, D. M., Wang, W., Peng, R.-W., Dorn, P., \u0026 Marti, T. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/170479\u0022\u003EAn optimized protocol for the generation and monitoring of conditional orthotopic lung cancer in the KP mouse model using an adeno-associated virus vector compatible with biosafety level 1\u003C\/a\u003E. \u003Ci\u003ECancer Immunology, Immunotherapy : CII\u003C\/i\u003E, \u003Ci\u003E72\u003C\/i\u003E(12), 4457-4470.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Gao, Y., Xu, D., Xu, K., Shun-Qing, L., Yang, Z., Scherz, A., Hall, S., Forster, S., Berezowska, S. A., Yao, F., Ochsenbein, A., Marti, T., Kocher, G., Schmid, R., Dorn, P., \u0026 Peng, R.-W. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/190597\u0022\u003EMEK1 drives oncogenic signaling and interacts with PARP1 for genomic and metabolic homeostasis in malignant pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003ECell Death Discovery\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E(1), 55.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Xu, K., Ma, J., Hall, S. R. R., Peng, R.-W., Yang, H., \u0026 Yao, F. (2023). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/120483\u0022\u003EBattles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ETheranostics\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(2), 704-723.","year":2023,"type":"Journal Article (Review)"},{"title":"Xu, D., Liu, S., Wu, X., Marti, T., Dorn, P., Schmid, R., Peng, R.-W., \u0026 Shu, Y. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88429\u0022\u003EDissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(20).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Karatkevich, D., Deng, H., Gao, Y., Flint, E., Peng, R.-W., Schmid, R., Dorn, P., \u0026 Marti, T. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/88112\u0022\u003ESchedule-Dependent Treatment Increases Chemotherapy Efficacy in Malignant Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003EInternational Journal of Molecular Sciences\u003C\/i\u003E, \u003Ci\u003E23\u003C\/i\u003E(19).","year":2022,"type":"Journal Article (Original Article)"},{"title":"Gao, Y., Kruithof-de Julio, M., Peng, R.-W., \u0026 Dorn, P. (2022). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86685\u0022\u003EOrganoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(15).","year":2022,"type":"Journal Article (Review)"},{"title":"Yang, H., Yao, F., \u0026 Peng, R.-W. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86542\u0022\u003ERevisiting \u0022BAP1ness\u0022 in Malignant Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E17\u003C\/i\u003E(8), e67-e69.","year":2022,"type":"Journal Article (Further Contribution)"},{"title":"Deng, H., Gao, Y., Trappetti, V., Hertig, D., Karatkevich, D., Losmanov\u00e1, T., Urz\u00ec, C., Ge, H., van Geest, G. A., Bruggmann, R., Djonov, V. G., Nuoffer, J.-M., Vermathen, P., Zamboni, N., Riether, C., Ochsenbein, A., Peng, R.-W., Kocher, G., Schmid, R., \u2026 Marti, T. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/86329\u0022\u003ETargeting lactate dehydrogenase B-dependent mitochondrial metabolism affects tumor initiating cells and inhibits tumorigenesis of non-small cell lung cancer by inducing mtDNA damage\u003C\/a\u003E. \u003Ci\u003ECellular and Molecular Life Sciences\u003C\/i\u003E, \u003Ci\u003E79\u003C\/i\u003E(8), 445.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Sun, B., Fan, L., Ma, W., Xu, K., Hall, S. R. R., Wang, Z., Schmid, R., Peng, R.-W., Marti, T., Gao, W., Xu, J., Yang, W., \u0026 Yao, F. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/85084\u0022\u003EMulti-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma\u003C\/a\u003E. \u003Ci\u003ETheranostics\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(7), 3104-3130.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Yang, Z., Shun-Qing, L., Zhao, L., Yang, H., Marti, T., Heged\u00fcs, B., Gao, Y., Zheng, B., Chen, C., Wang, W., Dorn, P., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116231\u0022\u003EMetabolic synthetic lethality by targeting NOP56 and mTOR in KRAS-mutant lung cancer\u003C\/a\u003E. \u003Ci\u003EJournal of Experimental \u0026 Clinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(1), 25.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Ning, W., Yang, Z., Kocher, G., Dorn, P., \u0026 Peng, R.-W. (2022). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116235\u0022\u003EA Breakthrough Brought about by Targeting KRASG12C: Nonconformity Is Punished.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(2).","year":2022,"type":"Journal Article (Review)"},{"title":"Ning, W., Marti, T., Dorn, P., \u0026 Peng, R.-W. (2022). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116032\u0022\u003ENon-genetic adaptive resistance to KRASG12C inhibition: EMT is not the only culprit.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EFrontiers in Oncology\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E, 1004669.","year":2022,"type":"Journal Article (Review)"},{"title":"Yang, H., Berezowska, S. A., Dorn, P., Zens, P. I., Chen, P., Peng, R.-W., Marti, T., Kocher, G., Schmid, R., \u0026 Hall, S. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/116232\u0022\u003ETumor-infiltrating lymphocytes are functionally inactivated by CD90+ stromal cells and reactivated by combined Ibrutinib and Rapamycin in human pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003ETheranostics\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(1), 167-185.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Wang, L., Yang, H., Dorn, P., Berezowska, S. A., Blank, F., Wotzkow Alvarez, C., Marti, T., Peng, R.-W., Harrer, N., Sommergruber, W., Kocher, G., Schmid, R., \u0026 Hall, S. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/58817\u0022\u003EPeritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer\u003C\/a\u003E. \u003Ci\u003EEBioMedicine\u003C\/i\u003E, \u003Ci\u003E73\u003C\/i\u003E, 103664.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Yang, Z., Liang, S.-Q., Saliakoura, M., Yang, H., Vassella, E., Konstantinidou, G., Tschan, M., Heged\u00fcs, B., Zhao, L., Gao, Y., Xu, D., Deng, H., Marti, T., Kocher, G., Wang, W., Schmid, R., \u0026 Peng, R.-W. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/53752\u0022\u003ESynergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS-mutant cancer\u003C\/a\u003E. \u003Ci\u003EEMBO Molecular Medicine\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(9), e13193.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Ma, W., Sun, B., Fan, L., Xu, K., Hall, S., Al-Hurani, M., Schmid, R., Peng, R.-W., Hida, T., Wang, Z., \u0026 Yao, F. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/58818\u0022\u003ESmoking signature is superior to programmed death-ligand 1 expression in predicting pathological response to neoadjuvant immunotherapy in lung cancer patients\u003C\/a\u003E. \u003Ci\u003ETranslational Lung Cancer Research\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(9), 3807-3822.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Sun, B., Xu, K., He, Y., Zhang, T., Hall, S., Tan, S. T., Schmid, R., Peng, R.-W., Hu, G., \u0026 Yao, F. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45707\u0022\u003EPharmaco-transcriptomic correlation analysis reveals novel responsive signatures to HDAC inhibitors and identifies Dasatinib as a synergistic interactor in small-cell lung cancer\u003C\/a\u003E. \u003Ci\u003EEBioMedicine\u003C\/i\u003E, \u003Ci\u003E69\u003C\/i\u003E(103457), 103457.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Yang, Z., Liang, S.-Q., Yang, H., Xu, D., Bruggmann, R., Gao, Y., Deng, H., Berezowska, S. A., Hall, S., Marti, T., Kocher, G., Zhou, Q., Schmid, R., \u0026 Peng, R.-W. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45688\u0022\u003ECRISPR-Mediated Kinome Editing Prioritizes a Synergistic Combination Therapy for FGFR1-Amplified Lung Cancer\u003C\/a\u003E. \u003Ci\u003ECancer Research\u003C\/i\u003E, \u003Ci\u003E81\u003C\/i\u003E(11), 3121-3133.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Gao, Y., Zens, P. I., Su, M., Gemperli, C. A., Yang, H., Deng, H., Yang, Z., Xu, D., Hall, S., Berezowska, S. A., Dorn, P., Peng, R.-W., Schmid, R., Wang, W., \u0026 Marti, T. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45686\u0022\u003EChemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5\u2019-deoxy-5-fluorocytidine (5\u2019-DFCR)\u003C\/a\u003E. \u003Ci\u003EJournal of Experimental \u0026 Clinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E40\u003C\/i\u003E(1), 1-22.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Liang, S.-Q., Yang, Z., Yang, H., Bruggmann, R., Oberh\u00e4nsli, S., Berezowska, S. A., Marti, T., Hall, S., Dorn, P., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45687\u0022\u003EMalignant pleural mesothelioma co-opts BCL-XL and autophagy to escape apoptosis\u003C\/a\u003E. \u003Ci\u003ECell Death \u0026 Disease\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(4), 406.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Zhang, T., Sun, B., Zhong, C., Xu, K., Wang, Z., Hofman, P., Nagano, T., Legras, A., Breadner, D., Ricciuti, B., Divisi, D., Schmid, R., Peng, R.-W., Yang, H., \u0026 Yao, F. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45708\u0022\u003ETargeting histone deacetylase enhances the therapeutic effect of Erastin-induced ferroptosis in EGFR-activating mutant lung adenocarcinoma\u003C\/a\u003E. \u003Ci\u003ETranslational Lung Cancer Research\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(4), 1857-1872.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Hall, S., Sun, B., Zhao, L., Gao, Y., Schmid, R., Tan, S. T., Peng, R.-W., \u0026 Yao, F. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45710\u0022\u003ENF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(7).","year":2021,"type":"Journal Article (Original Article)"},{"title":"Ma, L., Andrieu, T., Mc Kinnon, B., D\u00fcmpelmann, L., Peng, R.-W., Wotzkow Alvarez, C., M\u00fcller, C., \u0026 Mueller, M. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45644\u0022\u003EEpithelial-to-mesenchymal transition contributes to the downregulation of progesterone receptor expression in endometriosis lesions\u003C\/a\u003E. \u003Ci\u003EJournal of Steroid Biochemistry and Molecular Biology\u003C\/i\u003E, \u003Ci\u003E212\u003C\/i\u003E, 105943.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Yao, F., Marti, T., Schmid, R., \u0026 Peng, R.-W. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45275\u0022\u003EBeyond DNA Repair: DNA-PKcs in Tumor Metastasis, Metabolism and Immunity.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(11).","year":2020,"type":"Journal Article (Review)"},{"title":"Yang, H., Zhao, L., Gao, Y., Yao, F., Marti, T., Schmid, R., \u0026 Peng, R.-W. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45276\u0022\u003EPharmacotranscriptomic Analysis Reveals Novel Drugs and Gene Networks Regulating Ferroptosis in Cancer\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(11).","year":2020,"type":"Journal Article (Original Article)"},{"title":"Wang, L., Dorn, P., Simillion, C., Froment, L., Berezowska, S. A., Tschanz, S. A., Haenni, B., Blank, F., Wotzkow Alvarez, C., Peng, R.-W., Marti, T., Bode, P. K., Moehrlen, U., Schmid, R., \u0026 Hall, S. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/44968\u0022\u003EEpCAM+CD73+ mark epithelial progenitor cells in postnatal human lung and is associated with pathogenesis of pulmonary disease including lung adenocarcinoma\u003C\/a\u003E. \u003Ci\u003EAmerican Journal of Physiology - Lung Cellular and Molecular Physiology\u003C\/i\u003E, \u003Ci\u003E319\u003C\/i\u003E(5), L794-L809.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Rossi Sebastiano, M., Pozzato, C., Saliakoura, M., Zhang, Y., Peng, R.-W., Gali\u00e8, M., Oberson, K., Simon, H.-U., Karamitopoulou Diamantis, E., \u0026 Konstantinidou, G. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/37998\u0022\u003EACSL3-PAI-1 signaling axis mediates tumor-stroma cross-talk promoting pancreatic cancer progression\u003C\/a\u003E. \u003Ci\u003EScience Advances\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(44), 1-15.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Xu, D., Yang, Z., Yao, F., Zhao, H., Schmid, R., \u0026 Peng, R.-W. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45020\u0022\u003ESystematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(8).","year":2020,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Xu, D., Gao, Y., Schmid, R., \u0026 Peng, R.-W. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45021\u0022\u003EOncolytic Viral Therapy for Malignant Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(7), e111-e113.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Wang, L., Dorn, P., Zeinali, S., Froment, L., Berezowska, S. A., Kocher, G., Alves, M. P., Br\u00fcgger, M., Oliveira Esteves Criblez, B. I., Blank, F., Wotzkow Alvarez, C., Steiner, S. K., Amacker, M., Peng, R.-W., Marti, T., Guenat, O. T., Bode, P. K., Moehrlen, U., Schmid, R., \u0026 Hall, S. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/190449\u0022\u003ECD90+CD146+ identifies a pulmonary mesenchymal cell subtype with both immune modulatory and perivascular-like function in postnatal human lung\u003C\/a\u003E. \u003Ci\u003EAmerican Journal of Physiology - Lung Cellular and Molecular Physiology\u003C\/i\u003E, \u003Ci\u003E318\u003C\/i\u003E(4), L813-L830.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Shun-Qing, L., Yang, H., Bruggmann, R., Berezowska, S. A., Zhang, Y., Marti, T., Hall, S., Gao, Y., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183265\u0022\u003ECRISPR screening identifies WEE1 as a combination target for standard chemotherapy in malignant pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003EMolecular Cancer Therapeutics\u003C\/i\u003E, \u003Ci\u003E19\u003C\/i\u003E(2), 661-672.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Mohsenzadegan, M., Peng, R.-W., \u0026 Roudi, R. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183011\u0022\u003EDendritic cell\/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EJournal of Cellular Physiology\u003C\/i\u003E, \u003Ci\u003E235\u003C\/i\u003E(1), 74-86.","year":2020,"type":"Journal Article (Review)"},{"title":"Yang, H., Xu, D., Schmid, R., \u0026 Peng, R.-W. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45274\u0022\u003EBiomarker-guided targeted and immunotherapies in malignant pleural mesothelioma.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ETherapeutic Advances in Medical Oncology\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E, 1758835920971421.","year":2020,"type":"Journal Article (Review)"},{"title":"Yang, H., Xu, D., Gao, Y., Schmid, R., \u0026 Peng, R.-W. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45022\u0022\u003EThe Association of BAP1 Loss-of-Function With the Defect in Homologous Recombination Repair and Sensitivity to PARP-Targeted Therapy\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(6), e88-e90.","year":2020,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Yang, H., Schmid, R., \u0026 Peng, R.-W. (2020). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/45278\u0022\u003ETherapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EFrontiers in Oncology\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E, 579464.","year":2020,"type":"Journal Article (Review)"},{"title":"Xu, D., Yang, H., Zhang, Y., Berezowska, S. A., Gao, Y., Shun-Qing, L., Marti, T., Hall, S., Dorn, P., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183006\u0022\u003EEndoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma\u003C\/a\u003E. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(10).","year":2019,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Shun-Qing, L., Xu, D., Zhang, Y., Marti, T., Gao, Y., Kocher, G., Zhao, H., Schmid, R., \u0026 Peng, R.-W. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183004\u0022\u003EHSP90\/AXL\/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer\u003C\/a\u003E. \u003Ci\u003EOncogenesis\u003C\/i\u003E, \u003Ci\u003E8\u003C\/i\u003E(9), 45.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Ti\u00e8che, C., Gao, Y., B\u00fchrer, E., Hobi, N., Berezowska, S. A., Wyler, K., Froment, L., Weis, S., Peng, R.-W., Bruggmann, R., Sch\u00e4r, P., Amrein, M. A., Hall, S., Dorn, P., Kocher, G., Riether, C., Ochsenbein, A., Schmid, R., \u0026 Marti, T. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/62201\u0022\u003ETumor Initiation Capacity and Therapy Resistance Are Differential Features of EMT-Related Subpopulations in the NSCLC Cell Line A549\u003C\/a\u003E. \u003Ci\u003ENeoplasia\u003C\/i\u003E, \u003Ci\u003E21\u003C\/i\u003E(2), 185-196.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Yang, H., Shun-Qing, L., Schmid, R., \u0026 Peng, R.-W. (2019). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/183007\u0022\u003ENew Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EFrontiers in Oncology\u003C\/i\u003E, \u003Ci\u003E9\u003C\/i\u003E, 953.","year":2019,"type":"Journal Article (Review)"},{"title":"Shun-Qing, L., B\u00fchrer, E., Berezowska, S. A., Marti, T., Xu, D., Froment, L., Yang, H., Hall, S., Vassella, E., Zhang, Y., Kocher, G., Amrein, M. A., Riether, C., Ochsenbein, A., Schmid, R., \u0026 Peng, R.-W. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/60122\u0022\u003EmTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer\u003C\/a\u003E. \u003Ci\u003EOncogene\u003C\/i\u003E, \u003Ci\u003E38\u003C\/i\u003E(5), 622-636.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Gao, Y., Dorn, P., Liu, S., Deng, H., Hall, S., Peng, R.-W., Schmid, R., \u0026 Marti, T. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/184182\u0022\u003ECisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment\u003C\/a\u003E. \u003Ci\u003ECancer Cell International\u003C\/i\u003E, \u003Ci\u003E19\u003C\/i\u003E(317), 317.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Xu, D., Shun-Qing, L., Yang, H., L\u00fcthi, U., Riether, C., Berezowska, S. A., Marti, T., Hall, S., Bruggmann, R., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/164016\u0022\u003EIncreased sensitivity to apoptosis upon endoplasmic reticulum stress-induced activation of the unfolded protein response in chemotherapy-resistant malignant pleural mesothelioma\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Cancer\u003C\/i\u003E, \u003Ci\u003E119\u003C\/i\u003E(1), 65-75.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Marti, T., Ti\u00e8che, C., Peng, R.-W., Hall, S., Froment, L., Dorn, P., Berezowska, S. A., \u0026 Schmid, R. (2017, May 7). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/157654\u0022\u003ECharacterizing the DNA damage response in putative stem cells of resected normal lung and matched NSCLC patient samples\u003C\/a\u003E. In \u003Ci\u003EAnnals of oncology\u003C\/i\u003E (Vols. 28, Issue suppl_2, p. ii4). Abstract Book of the European Lung Cancer Conference (ELCC), Geneva, Switzerland. Oxford University Press.","year":2017,"type":"Conference Paper (Abstract)"},{"title":"Bichsel, C., Wang, L., Froment, L., Berezowska, S. A., M\u00fcller, S. J., Dorn, P., Marti, T., Peng, R.-W., Geiser, T., Schmid, R., Guenat, O. T., \u0026 Hall, S. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/155085\u0022\u003EIncreased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model\u003C\/a\u003E. \u003Ci\u003EScientific Reports\u003C\/i\u003E, \u003Ci\u003E7\u003C\/i\u003E(1), 10636.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Hall, S., Wang, L., Marti, T., Peng, R.-W., Froment, L., Berezowska, S. A., Kocher, G., Dorn, P., \u0026 Schmid, R. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148859\u0022\u003E10PD\nAssessment of PD-L1 and CD47 expression together with tumor-associated TILs in resectable early stage NSCLC\u003C\/a\u003E. \u003Ci\u003EAnnals of Oncology\u003C\/i\u003E, \u003Ci\u003E27\u003C\/i\u003E(suppl_8), viii3.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Hall, S., Wang, L., Marti, T., Peng, R.-W., Froment, L., Berezowska, S. A., Kocher, G., Dorn, P., \u0026 Schmid, R. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148597\u0022\u003E98O: Characterization of tumor infiltrating lymphocytes in resectable early stage non-small cell lung cancer\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(4Suppl), S99.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Marti, T., Ti\u00e8che, C., Peng, R.-W., Dorn, P., Froment, L., \u0026 Schmid, R. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148629\u0022\u003E22P Increased schedule-dependent efficiency of pemetrexed-cisplatin combination therapy eliminates resistant lung cancer stem-like cells associated with EMT\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(4Suppl), S64-S65.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Shun-Qing, L., Marti, T., Dorn, P., Froment, L., Hall, S., Berezowska, S. A., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148631\u0022\u003E18P Epithelial-to-mesenchymal transition (EMT) is required for resistance to anti-folate chemotherapy in lung cancer\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(4Suppl), S63.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Marti, T., Dorn, P., Ti\u00e8che, C., Peng, R.-W., Froment, L., \u0026 Schmid, R. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148617\u0022\u003E23P Prolonged pemetrexed pretreatment increases efficiency of ionizing radiation combination therapy and correlates with the persistence of treatment-induced DNA damage in lung cancer cells\u003C\/a\u003E. \u003Ci\u003EJournal of Thoracic Oncology\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(4Suppl), S65.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Ti\u00e8che, C., Peng, R.-W., Dorn, P., Froment, L., Schmid, R., \u0026 Marti, T. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148637\u0022\u003EProlonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT\u003C\/a\u003E. \u003Ci\u003EBMC Cancer\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(125), 125.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Dorn, P., Ti\u00e8che, C., Peng, R.-W., Froment, L., Schmid, R., \u0026 Marti, T. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/148586\u0022\u003ESchedule-dependent increased efficiency of pemetrexed-ionizing radiation combination therapy elicits a differential DNA damage response in lung cancer cells\u003C\/a\u003E. \u003Ci\u003ECancer Cell International\u003C\/i\u003E, \u003Ci\u003E16\u003C\/i\u003E(66), 66.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Shun-Qing, L., Marti, T., Dorn, P., Froment, L., Hall, S., Berezowska, S. A., Kocher, G., Schmid, R., \u0026 Peng, R.-W. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/139407\u0022\u003EBlocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer\u003C\/a\u003E. \u003Ci\u003ECell Death \u0026 Disease\u003C\/i\u003E, \u003Ci\u003E6\u003C\/i\u003E(e1824), e1824.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Ruppen, J., Cortes-Dericks, L., Marconi, E., Karoubi, G., Schmid, R., Peng, R.-W., Marti, T., \u0026 Guenat, O. T. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/192292\u0022\u003EA microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids\u003C\/a\u003E. \u003Ci\u003ELab on a Chip\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(6), 1198-1205.","year":2014,"type":"Journal Article (Original Article)"}]}